Rite Aid

FemmePharma Global Healthcare was founded in 1996 to target high unmet medical needs within the estimated $70 billion women s health care pharmaceutical market. FemmePharma is committed to developing safe and effective drugs that minimize or eliminate the systemic side effects associated with many drug therapies by designing them in a way that is specifically suited to a woman s physiology with an eye toward the changing needs of women throughout their lives. FemmePharma currently has a product to treat urinary incontinence and has other products in the areas of mastalgia and dysfunctional uterine bleeding in development. FemmePharma Global Healthcare is in Wayne, Pa.

It takes a team effort to provide effective, compassionate care to those who need it, and our team at Medical Homecare is dedicated to serving those needs

Zynerba Pharmaceuticals, Inc. is an orphan-focused, neuropsychiatric biopharmaceutical company based in Devon, PA. They are dedicated to developing innovative transdermal cannabinoid treatments for patients with rare neurological diseases, with a particular focus on improving the lives of those battling certain rare conditions. Recently acquired by Harmony Biosciences, Zynerba Pharmaceuticals is at the forefront of pioneering cannabinoid therapies for neuropsychiatric conditions. Their ongoing RECONNECT clinical trial is open for recruitment, offering patients, families, and healthcare providers an opportunity to learn more about Fragile X syndrome and access potential treatments. With a mission to advance science and improve connections, Zynerba Pharmaceuticals is committed to addressing unmet medical needs in the field of rare disorders.Generated from the website